BackTG Therapeutics Overview

TG Therapeutics Inventory

Latest inventory for TGTX: $130M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$129.03M
18.21% YoYΔ $-28.73M vs prior year quarter

Peer average

Loading

TG Therapeutics Inventory History

Loading

TG Therapeutics vs. peers: Inventory Comparison

Loading

TG Therapeutics Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

TG Therapeutics (TGTX) FAQ

As of the most recent data (March 2026), TGTX shows a inventory of $130M. That compares with $160M in the prior-year period — down 18.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TGTX's inventory is now $130M (was $160M) — a 18.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether TG Therapeutics is outperforming or lagging.

Tracking TGTX's inventory over time shows whether TG Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $130M That compares with $160M in the prior-year period — down 18.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has TG Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $130M) with ownership activity and broader fundamentals.

TG Therapeutics's inventory is $130M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.